StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Shaking off the tree

<< Previous

Bullboard Posts

Next >>

Comment by RelevantStockon Feb 22, 2021 10:36am

100 Views

Post# 32625760

RE:RE:Shaking off the tree

GladiatorPower wrote:
a halt will be the mother and the father of all shaking trees in the world.

That will be epic. Knowing how JHT (and most CEO's) despise stock price manipulators, he will do his very best to catch them pants down.

There is also the fact though that a lot of the shaking off the tree is done by large investors that are important for the company, they just continue to accumulate even at these levels. That's why I am not worried at all since the catalysts are all ahead.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec